Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III Sells 3,000 Shares

Kewaunee Scientific Co. (NASDAQ:KEQU) CFO Donald T. Gardner III sold 3,000 shares of the business’s stock in a transaction that occurred on Wednesday, March 26th. The shares were sold at an average price of $40.01, for a total value of $120,030.00. Following the completion of the sale, the chief financial officer now owns 18,358 shares of the company’s stock, valued at $734,503.58. This trade represents a 14.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Kewaunee Scientific Price Performance

Shares of KEQU opened at $40.15 on Friday. The firm has a market capitalization of $114.63 million, a price-to-earnings ratio of 6.36 and a beta of 0.71. The stock’s fifty day moving average is $55.79 and its 200-day moving average is $47.44. Kewaunee Scientific Co. has a one year low of $30.82 and a one year high of $71.33. The company has a debt-to-equity ratio of 0.45, a quick ratio of 2.13 and a current ratio of 2.64.

Kewaunee Scientific (NASDAQ:KEQU) last released its quarterly earnings results on Wednesday, March 12th. The technology company reported $1.09 EPS for the quarter. The company had revenue of $67.17 million for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Hedge Funds Weigh In On Kewaunee Scientific

A number of institutional investors have recently bought and sold shares of the stock. De Lisle Partners LLP boosted its position in Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock worth $1,446,000 after acquiring an additional 11,511 shares during the period. State Street Corp purchased a new stake in Kewaunee Scientific in the 3rd quarter worth approximately $266,000. Barclays PLC acquired a new stake in shares of Kewaunee Scientific during the 3rd quarter valued at $121,000. Geode Capital Management LLC grew its holdings in shares of Kewaunee Scientific by 8.9% during the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after acquiring an additional 1,941 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Kewaunee Scientific by 18,000.0% in the third quarter. JPMorgan Chase & Co. now owns 905 shares of the technology company’s stock worth $30,000 after acquiring an additional 900 shares during the last quarter. Hedge funds and other institutional investors own 32.69% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded shares of Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Friday, March 14th.

About Kewaunee Scientific

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.